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Abstract
Background: Sepsis is a potentially deadly disease that often is caused by gram-positive bacteria, in particular
Staphylococcus aureus (S. aureus). As there are few effective therapies for sepsis, increased basic knowledge about factors
predisposing is needed.
Methodology/Principal Findings: The purpose of this study was to study the effect of Western diet on mortality induced by
intravenous S. aureus inoculation and the immune functions before and after bacterial inoculation. Here we show that
C57Bl/6 mice on high-fat diet (HFD) for 8 weeks, like genetically obese Ob/Ob mice on low-fat diet (LFD), have increased
mortality during S. aureus-induced sepsis compared with LFD-fed C57Bl/6 controls. Bacterial load in the kidneys 5–7 days
after inoculation was increased 10-fold in HFD-fed compared with LFD-fed mice. At that time, HFD-fed mice had increased
serum levels and fat mRNA expression of the immune suppressing cytokines interleukin-1 receptor antagonist (IL-1Ra) and
IL-10 compared with LFD-fed mice. In addition, HFD-fed mice had increased serum levels of the pro-inflammatory IL-1b.
Also, HFD-fed mice with and without infection had increased levels of macrophages in fat. The proportion and function of
phagocytosing granulocytes, and the production of reactive oxygen species (ROS) by peritoneal lavage cells were decreased
in HFD-fed compared with LFD-fed mice.
Conclusions: Our findings imply that chronic HFD disturb several innate immune functions in mice, and impairs the ability
to clear S. aureus and survive sepsis.
Citation: Strandberg L, Verdrengh M, Enge M, Andersson N, Amu S, et al. (2009) Mice Chronically Fed High-Fat Diet Have Increased Mortality and Disturbed
Immune Response in Sepsis. PLoS ONE 4(10): e7605. doi:10.1371/journal.pone.0007605
Editor: Malcolm James Horsburgh, University of Liverpool, United Kingdom
Received July 17, 2009; Accepted October 2, 2009; Published October 28, 2009
Copyright:  2009 Strandberg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Swedish Research Council (No K2007-54X-09894-16-3, http://www.vr.se/), EC FP6 funding (contract no. LSHM-CT-
2003-503041; http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/l_fp6_en.htm), Novo Nordisk Foundation (http://www.
novonordiskfonden.dk/en/index.asp), Lars Hierta Memorial Foundation (http://www.larshiertasminne.se/), Anders Otto Swa ¨rds Foundation http://www.
catellasponsor.se/1266.aspx), and Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR, no. A305:188; http://www.cmr.gu.se/), which is
supported by the Swedish Strategic Foundation (http://www.stratresearch.se/). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: JOJ@medic.gu.se
¤a Current address: Institute of Molecular Medicine, Trinity Center, St James Hospital, Dublin, Ireland
¤b Current address: Garvan Institute for Medical Research, Darlinghurst Sydney, Australia
Introduction
Sepsis is often a deadly disease with increasing incidence
worldwide [1]. Gram-positive bacteria, in particular Staphylococcus
aureus (S. aureus), are a predominant and increasing cause of sepsis
[1,2]. Sepsis consists of a hyperinflammatory state during the first
few days followed by a prolonged hypoimmune state during which
death often occurs [3,4]. At present, there are few treatments for
sepsis, besides antibiotics [3,5], and antibiotic resistance is
increasing globally [6]. In addition, few treatments for sepsis
developed in experimental animals have resulted in clinical use
[4,5]. Therefore, increased basic knowledge about factors
predisposing to this deadly disease is urgently needed.
Like sepsis, obesity is increasing epidemically and this is believed
to be due to the consumption of energy dense food, such as fat rich
diets, combined with polygenetically determined susceptibility
[7,8]. There may be interactions between the immune system and
body fat metabolism. The adipose tissue of obese and insulin
resistant individuals can produce and release cytokines, first shown
by Hotamisligil & Spiegelman for tumor necrosis factor (TNF)-a
[9]. More recently, it has been suggested that macrophages
accumulating in fat [10,11] contribute to obesity-induced cytokine
release and low-grade inflammation, which in turn could cause
insulin resistance and atherosclerosis in obese subjects [10–12].
Considerably less is known about how this condition may influence
the main task of the immune system, to combat infections. Clinical
findings indicate that obesity is associated with increased
susceptibility to infections [13]. However, this association could
be due to multiple factors, e.g. longer surgery and hospitalization
time of obese patients, with increased risk for nosocomial
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immune defects. Previous studies have shown that innate immune
dysfunction, associated with absence of interleukin-6 (IL-6),
granulocyte-macrophage colony-stimulating factor, IL-1RI, and
IL-18, leads to obesity [14–19]. Conversely, ingestion of energy
dense food and obesity may suppress the immune response. In
clinical materials it is very difficult to clarify the possible causality
as well as cellular and molecular links between obesity and
potential defective immune function.
In the present study we used an animal model to determine
whether ingestion of fat with resulting obesity can affect the
capacity of the immune system to resist bacterial sepsis. We studied
chronic high-fat diet (HFD) fed mice, which have been shown to
reflect common forms of clinical obesity and obesity related disease
that depend on multiple genetic factors as well as diet [20,21]. The
bacterial challenge model used in this study was injection of S.
aureus, a common cause of sepsis in humans.
Methods
Ethics statement
The experiments were performed with the approval of the
Ethical Committee of University of Gothenburg.
Experimental protocol. Male C57BL/6 mice 5–7 weeks old
were obtained from Harlan Netherlands B.V. (Horst, The
Netherlands). Male Ob/Ob mice and C57BL/6 control mice
were obtained from Harlan UK Limited (Bicester, England). The
mice were housed in the animal facility of the Department of
Rheumatology and Inflammation Research or at the Laboratory
for Experimental Biomedicine, University of Gothenburg,
Sweden, under standard conditions of light and temperature.
Food and water were provided ad libitum. Starting at 6–8 weeks of
age C57BL/6 mice was fed either HFD or LFD for 8 weeks, while
Ob/Ob mice were fed LFD. At 14–16 weeks of age the mice were
either terminated or infected with S. aureus. The experiments were
terminated 1 or 5–7 days after inoculation for mechanistic studies
and 17 days after bacterial inoculation for observational studies on
mortality. Results from different studies were pooled if similar.
The mice received four different diets. LFD R36 (3 kcal/g,
4 g% fat, 18.5 g% protein, 55.7 g% carbohydrate; Lactamin AB,
Stockholm, Sweden) was given in experiments with HFD D12309
(5.6 kcal/g, 35.9 g% fat, 23 g% protein, 35.5 g% carbohydrate;
Research Diets, New Brunswick, NJ). LFD D12450B (3.85 kcal/g,
4.3 g% fat, 19.2 g% protein, 67.3 g% carbohydrate; Research
Diets) was given in experiments with HFD D12492 (5.24 kcal/g,
34.9 g% fat, 26.2 g% protein, 26.2 g% carbohydrate; Research
Diets). The two latter diets are matched to have similar content
except for fat concentration. There were no obvious differences
between the experimental results obtained with these two pairs of
diets. In order to study short- versus long-term effects of HFD we
studied 4 groups of mice. Mice were fed LFD (LFDRLFD) or
HFD (HFDRHFD) before and after bacterial inoculation, we also
studied mice on LFD which were switched to HFD on the day of
inoculation (LFDRHFD) as well as mice on HFD that were
switched to LFD on the day of inoculation (HFDRLFD).
S. aureus inoculation. Mice were inoculated by an
intravenously injection, in the tail vein, with 0.2 ml of S. aureus
LS-1 solution containing 5610
7 colony forming units (CFU), as
previously described [22]. After 1 or 5–7 days after inoculation the
kidneys were aseptically removed and homogenized in phosphate
buffered saline (PBS). Blood was also obtained 1 day following
inoculation. Appropriate dilutions were made and 0.1 ml of tissue
suspensions or blood was plated on agar plates containing 5%
horse blood. After 24 hour incubation at 37uC the staphylococcal
colonies were counted.
Analysis of body composition. Fat and lean body mass
were analysed three days before inoculation by dual-energy
X-ray absorptiometry (PIXImus2, Lunar GE Medical systems,
Madison, WI). The mice were under inhalation anesthesia with
Isoflurane (Forene, Abbot Scandinavia, Solna, Sweden) during the
measurement.
Serum cytokine measurements. IL-1Ra was measured
using enzyme-linked immunosorbent assay (R&D, Abingdon,
UK) according to the manufacturer’s protocol. IL-10, IL-6,
TNF-a, and IL-1b were measured with Bio-Plex mouse cytokine
assays (Bio-Rad Laboratories AB, Sundbyberg, Sweden), as
previously described [23].
mRNA expression. Total RNA from snap frozen liver,
spleen and gonadal adipose tissue was extracted using RNeasy
Lipid Tissue Mini Kit and RNase-Free DNase Set (Qiagen,
Valencia, CA). cDNA synthesis was performed in duplicates using
iScript cDNA synthesis kit (Bio-Rad, Hercules, CA).
Quantification of mRNA expression was performed using real
time reverse transcriptase (RT)-PCR. SYBR Green detection
(Power SYBRH Green PCR Master Mix, Applied Biosystems,
Warrington, UK), was used for Il1rn, Il1b, Il10, and Tnf. Melting
curves were run to verify PCR products. Probe detection
(TaqManH Gene Expression Master Mix, Applied Biosystems)
was used for Il6 and Emr1. The pooled cDNA was run in
triplicates along with the following controls: no RT control,
negative RT control, and non-template control. The amount of
cDNA in each well was equivalent to 50 ng of mRNA and Eef2
was used as the reference gene. Sequences for primers and assay
numbers are shown in Table S1. Gene expression values were
calculated based on the DDCt method [24] where the uninfected
LFD-fed group was designated the calibrator. Briefly, DCt
represents the threshold cycle (Ct) of the target minus that of the
reference gene and DDCt represents the DCt of each target minus
that of the calibrator. Relative quantities were determined using
the equation; relative quantity=2
2DDCt. For the calibrator sample,
the equation is relative quantity =2
20, which is 1; therefore, every
other sample is expressed relative to this.
Flow cytometry. Peripheral blood was collected in
heparinized tubes and total leukocyte counts were determined in
a hemacytometer (Toa Medical Electronics, Kobe, Japan). Blood
smears were prepared and stained by the May-Grunewald-Giemsa
method for differential counts. Spleens were collected and stored
in PBS until preparation.
To obtain a spleen single cell suspension for flow cytometry
analysis, the spleen was homogenized and run through a nylon
filter to remove debris. For removing of erythrocytes blood and
cell suspension of spleen were resuspended in NH4Cl (0.83%,
pH 7.29) and kept on ice for 7 min, washed twice in cold PBS, and
finally resuspended in fluorescent-activated cell sorting (FACS)-
buffer (containing 1% FCS, 0.1% NaN3, 1% EDTA and PBS).
Thereafter, 10
5–10
6 cells were placed in 96-well plates and
pelleted (3 min, 300 g,4 uC). Antibodies were diluted in FACS-
buffer to optimal concentrations. The monoclonal antibodies used
were directly conjugated with allophycocyanin, fluorescein
isothiocyanate (FITC), pacific blue, peridinin-chlorophyll-protein
or biotin. Antibodies conjugated with biotin were further exposed
to streptavidin-conjugated allophycocyanin. Antibodies used
included clone 6F12 directed against Emr4 (also called FIRE),
and its detection antibody RG7/1.30. Antibodies were also
directed against CD19 (1D3), Emr1 (BM8), CD4 (RM4-5), and
CD8 (53–6.7). An isotype control for the biotinylated antibody was
run at the same time (i.e. rat IgG2b, k,A95-1). In addition,
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used as background levels for each staining when staining samples
with multiple antibodies and fluorochromes [25]. Using FMO
settings, the samples are stained with the regular antibodies used in
the test covering all flourochromes except one. Analyzing this
‘‘empty’’ channel will give a correct background (i.e. leakage of the
other fluorochromes in this channel). This background will then be
the base level when analyzing the sample stained with this
fluorochrome. As can be seen from the included example of a flow
cytometry plot gated with FMO, there is no substantial over- or
under-estimation using this method (Fig. S1). This is in line with
previous conclusions that FMO settings give lower risk for
incorrect gating compared to when isotypes are used [25].
Antibodies were purchased from either BD Bioscience (Erembo-
degem, Belgium) or E-Bioscience (San Diego, CA).
To avoid unspecific binding via Fc-receptor interactions, cells
were incubated with Fc block (2,4G2, BD Bioscience) for 10 min at
room temperature. Cells were then incubated with antibodies for a
minimum of 20 min at 4uC in the dark followed by two washing
steps with cold FACS-buffer. Biotin-conjugated antibodies were
incubated in one additional step with streptavidin (allophycocya-
nin) for minimum of 20 min at 4uC in the dark. After further
washing steps cells were resuspended in FACS-buffer before
analyses. 2610
421610
5 cells were collected using a FACSCantoII
(BD Bioscience). Instrument setting was performed using Comp-
Beads from BD Bioscience and data analyses were performed
using the FlowJo software, (Tree Star Inc, Ashland, OR). The
background has been subtracted from all presented data.
Phagocytic activity analysis. Number and activity of
phagocytic cells from whole blood were determined using a
commercially available kit (PhagotestH, Orpegen Pharma,
Heidelberg, Germany) according to the manufacturer’s
instructions, except for the use of FITC-labeled S. aureus, instead
of Escherichia coli. In brief, heparinized blood was incubated with
FITC-labeled bacteria for 10 min at 37uC, before cooling on ice
and addition of quenching solution. Thereafter, the samples are
washed, lysed, fixed, washed and stained for DNA, before flow
cytometric analysis. The quenching solution of the Phagotest assay
allows the discrimination between attachment and internalisation
of bacteria by quenching the FITC fluorescence of surface bound
bacteria and still leaving the fluorescence of internalized bacteria
unaltered.
Reactive oxygen species (ROS) production from
peritoneal lavage cells. Cells from peritoneal cavity were
collected after an injection of 3 ml sterile PBS into the peritoneum
followed by a massage of abdomen and collection of the fluid. The
cells were then used for measurement of ROS production. An
isoluminol-enhanced chemiluminescence (ECL) system was used
with a Mithras LB940 (Berthold technologies, Bad Wildbad,
Germany) plate reader and disposable 96-well plates containing
200-ml reaction mixtures. Each well contained 2610
5 cells, horse-
radish peroxidase (4 U ml
21) and isoluminol (20 mM) in Krebs-
Ringer phosphate buffer (pH 7.3) containing glucose (10 mM),
Ca
2+ (1 mM), and Mg
2+ (1.5 mM; KRG). The cells were
transferred to 37uC, stimulated with phorbol myristate acetate
(PMA; 50 nM) or left unstimulated. Light emission was recorded
continuously and data are expressed as relative light units; details
on the ECL system can be found in [26].
ROS production from bone marrow neutrophils. Bone
marrow neutrophils were purified as previously described [27].
Femurs and tibias were collected from both hind limbs and freed
of soft tissue. The bones were flushed through with ice cold KRG
without Ca
2+ and the collected cell suspension was filtered through
a4 0mm nylon cell strainer and pelleted by centrifugation at 200 g.
The pellet was resuspended in cold KRG without Ca
2+ and laid on
top of a three layer gradient, 2 ml each of 1.095, 1.085, and
1.070 g ml
21 Percoll solutions and centrifuged at 500 g for 30 min
at 4uC without brake. The interface containing neutrophils
between the first and the second layer (1.085/1.095 g ml
21) was
collected, washed and then resuspended in KRG. The red blood
cells were removed through hypotonic lysis. The purity of mature
neutrophils (.80%) was determined by cytospin and May-
Grunwald Giemsa staining; remaining cells seemed to be mainly
different kinds of immature leucocytes in line with earlier results
[28].
Neutrophil superoxide anion production was measured using
the isoluminol-ECL system as described above using a six-channel
Biolumat LB 9505 apparatus (Berthold technologies) with 4-ml
disposable polypropene tubes and 0.9 ml reaction mixtures. After
equilibration for 5 min at 37uC, 0.1 ml stimulus was added and
light emission recoded continuously. The samples were stimulated
with D-peptide (WKYMVm; 0.1 mM) [27], PMA (50 nM), or
opsonized S. aureus (10 bacteria/cell).
Opsonized bacteria were obtained by washing S. aureus in PBS
followed by dilution in HBSS, including 20% mouse serum and
0.1% gelatin (GHBSS), and incubated for 30 min in 37uCo na
shaker. The bacteria were then washed twice in GHBSS and then
diluted in GHBSS and counted in a Burker chamber.
Statistical analysis. Statistical analyses were performed
using the SPSS software (version 15.0.1 for Windows). We used
2-samples Student’s t-test; whenever Levene’s test revealed
unequal variance we used Welch’s t-test, for comparisons of
numeric data between two experimental groups. When
adjustments for covariates were needed, e.g. when outcomes
could not be pooled between experiments, we instead used
ANCOVA. Logarithmic transformations were used when
appropriate to ensure normal distribution of data. Mann-
Whitney test was used when other tests were not appropriate.
Log rank test were used for analysis of mortality. Fold changes
were calculated as a ratio between mRNA expression and the
geometrical mean of the control group (uninfected or infected
LFD-fed mice) mRNA expression. Differences in n are due to
different number of mice at the start of experiment, mortality or
laboratory errors. All tests are two-sided. Data are arithmetic
mean6SEM or geometrical mean when log data are used, unless
otherwise stated, and P ,0.05 was considered significant.
Results
Increased mortality in HFD-fed mice after S. aureus
inoculation
After 8 weeks on HFD, C57BL/6 mice had increased body
weight and fat mass compared with LFD-fed mice (Table S2). The
S. aureus-induced mortality in mice fed HFD during the entire
experiment (HFDRHFD) was increased when compared with
mice on LFD during the whole period (LFDRLFD), an effect
apparent at 5–7 days after bacterial inoculation (P=0.02, Fig. 1A).
This difference has been confirmed (data not shown). There was
no increase in mortality when comparing mice that had been
switched from LFD to HFD at the day of staphylococcal
inoculation (LFDRHFD) with mice that had been fed LFD
throughout (P=0.9, Fig. 1A). Moreover, there was no significant
difference in mortality between mice fed HFD before inoculation
and switched to LFD at the day of inoculation (HFDRLFD), and
mice that were on HFD throughout (P=1, Fig. 1A).
To investigate if the increased mortality in HFD-fed mice was
due to under- or over-reactivity of the immune system, we
measured bacterial load in blood and kidneys on day 1 and in
HFD, Sepsis & Mortality
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no difference in bacterial load in either blood or kidneys 1 day
after inoculation (Fig. S2). However, 5–7 days after inoculation
there was a 10-fold increase in the number of staphylococcal CFU
in the kidneys from HFD-fed mice, compared with LFD-fed mice
(P=0.001, Fig. 1B).
To investigate whether sepsis-induced mortality could be
affected by obesity in the absence of HFD, genetically obese
leptin deficient Ob/Ob mice were given LFD throughout the
experiment. These obese mice showed increased mortality when
infected with S. aureus compared with LFD-fed C57Bl/6 mice
(P=0.005, Fig. 1C).
Increased cytokines in serum of infected HFD-fed mice
We measured several serum cytokines in uninfected and
infected mice. In uninfected mice the only difference was seen in
the levels of the anti-inflammatory cytokine IL-1Ra, which were
increased in HFD-fed mice (169 (range: 33–1111) and 1587
(range: 84–32245) pg ml
21, for LFD- vs. HFD-fed mice, P,0.001,
ANCOVA on log data with experiment as covariate, data from 4
different experiments, n=28+26). Infected HFD-fed mice had 4.9-
fold increased levels of IL-1Ra (P,0.001) and also 4.7-fold
increased levels of another anti-inflammatory cytokine, IL-10
(P,0.001, Fig. 2A and B). IL-6 has pro-inflammatory functions,
but has also been found to have anti-inflammatory effects [29,30].
This cytokine was increased in four HFD-fed mice, but overall not
significantly (Fig. 2C). Among the pro-inflammatory cytokines
measured, IL-1b was increased (P=0.02) and there was a
tendency for increased TNF-a in HFD-fed mice, compared with
LFD-fed mice (Fig. 2D and E).
Increased mRNA expression of cytokines in fat of HFD-
fed mice
We investigated mRNA expression of several cytokines in fat,
liver and spleen in uninfected and infected mice. All measured
cytokines, both anti-and pro-inflammatory, were significantly up-
regulated in fat from uninfected HFD-fed mice compared with
uninfected LFD-fed mice (P,0.001, Fig. 3A–E). The largest
increase was seen in IL-1Ra gene (Il1rn) expression, which was up
regulated 155-fold. In liver we also found an increase in Il1rn
(P=0.03, Fig. S3A) and a decrease of Il6 and Il1b in uninfected
HFD-fed mice (P#0.001, Fig. S3C and D), while there was no
difference in spleen of uninfected mice (Fig. S4A–E).
In infected mice, there were 13- and 2.9-fold increases of the
anti-inflammatory cytokines Il1rn and Il10, respectively in fat from
HFD-fed mice as compared with LFD-fed mice (P,0.001, Fig. 3A
and B). The expression of the pro-inflammatory cytokine Tnf was
increased 4.6-fold in HFD-fed mice (P,0.001), whereas the
expression of Il1b and Il6 did not differ between groups (Fig. 3C–
E). In liver from infected HFD-fed mice there was a 2.6-fold
decrease in Il1b expression (P,0.001, Fig. S3D). As in uninfected
mice, there was no difference in expression in the spleen (Fig.
S4A–E).
The relative increase in Il1rn mRNA (HFD versus LFD) was
155-fold in uninfected and only 13-fold in infected mice (Fig. 3A).
However, the absolute difference between LFD and HFD was 154
units before infection and 974 units after infection. Based on this
calculation, the difference in Il1rn expression between LFD and
HFD would actually be larger rather than smaller after infection.
Increased proportion but decreased function of
monocytes in HFD-fed mice. FACS analysis of the
monocyte/macrophage marker Emr4 (also called FIRE) showed
a 60% increase (P,0.001) in the blood proportion of monocytes in
uninfected HFD-fed mice compared with LFD-fed mice, but after
bacterial inoculation there was instead a 70% decrease (P=0.02,
Fig. 4A). Similar results were obtained when measuring another
marker of monocytes/macrophages Emr1 (also known as F4/80,
data not shown). The mRNA expression of Emr1 in fat was
increased 6.3-fold (P=0.003) in uninfected HFD-fed mice
compared with LFD-fed mice, as expected [10,11]. Also infected
Figure 1. Survival and bacterial load after intravenous S. aureus
inoculation. (A) Survival in mice fed: LFD before and after bacterial
inoculation (LFDRLFD, n=21), LFD before and HFD after bacterial
inoculation (LFDRHFD, n=10), HFD before and after bacterial
inoculation (HFDRHFD, n=18), HFD before and LFD after bacterial
inoculation (HFDRLFD, n=12). The HFDRHFD group had increased
mortality, compared with LFDRLFD mice (P=0.02). There was no
difference between the LFDRHFD and LFDRLFD group (P=0.9), or
between the HFDRLFD group (P=1). Log rank test. Data were
collected from 2 different experiments. (B) Bacterial load in kidneys
5–7 days after bacterial inoculation in LFD- (n=7) and HFD-fed (n=6)
mice. Mann-Whitney. Data are depicted as actual values or lowest/
highest measurable value if not determinable. Detection limit is
,0.01 CFU/2 kidneys (610
6), shown by the dotted line. Points represent
individual mice; group median are denoted by a line throughout. (C)
Survival in LFD-fed C57BL/6 (n=15) and Ob/Ob (n=18) mice after S.
aureus inoculation. Ob/Ob mice had increased mortality compared with
LFD-fed C57Bl/6 mice (P=0.005). Log rank test.
doi:10.1371/journal.pone.0007605.g001
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Fig. 4B).
Uninfected HFD-fed mice had a lower proportion of phagocy-
tosing monocytes than LFD-fed mice (P=0.01, Fig. 4C). However,
a measure of ingested number of bacteria per monocyte did not
differ between groups (Fig. 4D). Phagocytic activity in infected
mice could not be determined due to small samples and few
monocytes.
The proportion of blood T- and B-cells measured by FACS in
uninfected mice did not differ between groups (data not shown).
Decreased neutrophil proportion and function in HFD-
fed mice. There was a decrease in the percentage (P,0.001) of
neutrophilic granulocytes in the blood of uninfected HFD-fed
mice, but 5–7 days after bacterial inoculation there was instead an
increase (P=0.02), compared with LFD-fed mice (Fig. 5A).
Granulocytes were tested for phagocytic activity both in
uninfected mice and 5–7 days after bacterial inoculation. In the
uninfected HFD-fed mice the proportion of granulocytes that were
able to phagocytize staphylococci was decreased by 40%,
compared with LFD-fed mice (P=0.004). However, 5–7 days
after bacterial inoculation there was no difference between groups
(Fig. 5B). Furthermore, granulocytes from uninfected HFD-fed
mice ingested fewer bacteria per granulocyte (P=0.02, Fig. 5C).
Decreased phagocytic ROS production in HFD-fed
mice. Neutrophilic granulocytes and macrophages are both
capable of ROS production that contributes to microbial killing.
We measured the capacity of peritoneal lavage cells, containing
neutrophils, macrophages and lymphocytes, to secrete ROS 5–7
days after S. aureus inoculation. Unstimulated lavage cells from
HFD-fed mice produced only 7% of the ROS produced in lavage
cells from LFD-fed mice (P,0.001, Fig. 6). In contrast, the
maximal capacity of ROS production, as measured after PMA
stimulation, did not differ between groups (Fig. 6). The cell
composition of lavage samples did not differ significantly between
the different diets (not shown).
To find out if the ability to produce ROS was altered already
before entering the blood circulation we isolated granulocytes from
bone marrow. The granulocytes were then stimulated with D-
peptide, live opsonized S. aureus, or PMA. No differences in ROS
production were detected between cells from HFD-fed and LFD-
fed mice (data not shown).
Decreased spleen weight and changed spleen leukocyte
population in HFD-fed mice. The spleen weight in uninfected
mice was increased in HFD-fed mice compared with LFD-fed
mice (P=0.04, Fig. 7A). After body weight adjustment, this
difference was however not significant (P=0.07). The spleens from
HFD-fed mice contained more white blood cells than those from
LFD-fed mice (34.563.1 vs. 22.462.3 (610
9 l
21), P=0.009,
Student’s t-test, n=7+8). However, after adjustment for spleen
weight, this difference lost significance (P=0.1). Furthermore, the
spleen weight was 40% lower in HFD-fed mice, compared with
LFD-fed mice, when weighed 5–7 days after bacterial inoculation
(P,0.001, Fig. 7A). The decreased spleen weight was also highly
significant after body weight adjustment (P=0.004).
The leukocyte population in the spleen was examined by FACS.
The monocyte proportion (Emr1
+ cells) was 2.8-fold higher in
uninfected HFD-fed mice than in LFD-fed mice (P,0.001,
Fig. 7B). The cytotoxic T (CD8
+)-cell proportion was slightly
lower in HFD-fed mice than in LFD-fed mice (P=0.04), while
there was no difference in B (CD19
+)-cell or T (CD4
+)-helper cell
proportion between groups (Fig. 7B).
Discussion
HFD-fed mice had increased delayed mortality in S. aureus-
induced sepsis from about one week after bacterial inoculation.
Acute administration of HFD at the time of inoculation did not
lead to increased mortality. This indicates that the increased
mortality in HFD-fed mice is due to chronic effects of the diet, for
example obesity, rather than short-term effects of the HFD. The
finding that genetically-induced obese Ob/Ob mice given LFD
also display increased mortality supports this notion. The
increased mortality appears to be due to an under reactivity of
the innate immune system, as an increased bacterial load was
found in the kidneys of HFD-fed mice. The reason for this
disturbed innate immune function is unknown, but we observed
several possible mechanisms. The anti-inflammatory cytokine IL-
1Ra was increased in serum and fat in both uninfected and
infected HFD-fed mice compared with LFD-fed mice. The other
measured anti-inflammatory cytokine, IL-10, was increased in
serum in infected HFD-fed mice, and in fat in uninfected and
infected HFD-fed mice. However, the serum levels of the pro-
Figure 2. Cytokine levels in serum, 5–7 days after bacterial
inoculation. (A) Serum levels of IL-1Ra in LFD- (n=26) and HFD-fed
(n=23) mice. Detection limit is ,31 pg/ml. Student’s t-test on log data.
(B) Serum levels of IL-10 in LFD- (n=25) and HFD-fed (n=21) mice.
Detection limit is ,13 pg/ml. Mann-Whitney. (C) Serum levels of IL-6 in
LFD- (n=25) and HFD-fed (n=21) mice. Detection limit is ,1.3 pg/ml.
ANCOVA on log data with experiment as covariate. (D) Serum levels of
IL-1b in LFD- (n=25) and HFD-fed (n=21) mice. Detection limit is
,2 pg/ml. Student’s t-test on log data. (E) Serum levels of TNF-a in LFD-
(n=25) and HFD-fed (n=21) mice. Detection limit is ,5.2 pg/ml.
ANCOVA on log data with experiment as covariate. Data were collected
from 3 different experiments. Data are depicted as actual values or
lowest measurable value if not determinable; detection limit is denoted
by the dotted line. In the scatter graphs, points represent individual
mice; group means/medians are denoted by a line throughout.
doi:10.1371/journal.pone.0007605.g002
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of the TNF-a and IL-6 tended to be increased in HFD-fed mice.
In summary, both pro-inflammatory and anti-inflammatory
cytokines were enhanced in mice given HFD. In addition, both
the proportion and function of granulocytes were decreased in
uninfected HFD-fed mice, and the ROS production by phagocy-
tosing cells was greatly decreased in infected HFD-fed mice.
Therefore, several immune functions were disturbed in chronically
HFD-fed mice.
The finding that the HFD-fed mice had some signs of decreased
immune response during infection was surprising, as data in
the literature clearly show that uninfected HFD-fed mice
have a chronic inflammation, i.e. stimulated immune functions
[9–12,31,32]. Although the immune system of obese individuals is
thus activated already at the time of infection, our results show
that this chronic activation does not facilitate immune system
activation and pathogen clearance during infection. If anything,
chronic inflammation seems associated with impaired effective-
ness of the immune system. In line with our findings, the
autoimmune diseases rheumatoid arthritis and systemic lupus
erythematosus are associated with increased risk of acquiring
infections, an event seemingly independent of immunosuppressive
treatments [33,34].
Obesity has been shown to up-regulate production of both pro-
and anti-inflammatory cytokines, from adipocytes and/or fat
infiltrating macrophages [9–12,35–37], as consistent with the
present findings in uninfected HFD-fed mice. The anti-inflamma-
tory cytokines IL-1Ra and IL-10 were both markedly up-regulated
in fat and serum in HFD-fed mice on day 5–7 after bacterial
challenge. At this time point HFD-fed mice have increased
bacterial load and their mortality starts to increase. IL-1b was the
only measured pro-inflammatory cytokine that then was higher in
serum of HFD-fed mice, although there was a tendency for
increased TNF-a and IL-6. The relatively large up-regulation of
anti- versus pro-inflammatory cytokines in serum may be
important for the decreased survival of HFD-fed mice in this
study. The mortality in clinical sepsis often occurs days to weeks
after the first clinical event and is associated with a shift toward an
immunosuppressive state [3,4]. In fact, it has been shown that IL-
1Ra treatment before inoculation enhances mortality in experi-
mental sepsis [38] and IL-10 neutralization has also been shown to
enhance survival to sepsis [39].
In the present study we confirm earlier findings that uninfected
HFD-fed mice accumulate macrophages in fat [10,11]. They also
have higher monocyte/macrophage proportion in blood and
spleen. When infected, HFD-fed mice still have an accumulation
Figure 3. Cytokine mRNA expression in gonadal adipose tissue. (A–E) mRNA expression was measured in uninfected LFD- (n=8) and HFD-
fed (n=8) mice, and in LFD- (n=13) and HFD-fed (n=9) mice 5–7 days after bacterial inoculation. mRNA from the following cytokine genes was
measured: (A) Il1rn, (B) Il10, (C) Il6, (D) Il1b, and (E) Tnf,. Welch’s test. In the scatter graphs, points represent individual mice (fold change as compared
with uninfected LFD-fed mice); group geometrical means are denoted by a line throughout. Statistical comparisons are made between LFD- and
HFD-fed mice in both infected and uninfected animals.
doi:10.1371/journal.pone.0007605.g003
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a lower monocyte proportion in blood, and the proportion of
phagocytosing monocytes was decreased in uninfected HFD-fed
mice. At present, it is unclear to what extent decreased
macrophage function contributes to decreased immune response
to S. aureus in HFD-fed mice.
We observed several signs of decreased granulocyte/neutrophil
efficacy in HFD-fed mice, including decreased proportion in blood
of neutrophils, decreased proportion of phagocytosing granulo-
cytes, and fewer ingested bacteria per granulocyte in uninfected
HFD-fed mice. There was also a marked decrease in ROS
production by phagocytic cells in infected HFD-fed mice.
Neutrophilic dysfunction clearly contributes to increased bacterial
growth and increased mortality [40–42], reasonably also in HFD-
fed mice. Indeed, neutrophils, the major subpopulation of
granulocytes, are often first to migrate into tissues in response to
invading pathogens and to attack bacteria in the blood circulation
[43,44]. Neutrophilic depletion in mice leads to severely increased
mortality in S. aureus-induced sepsis [22]. Furthermore, most
patients with congenital neutropenia, also known as Kostmann
syndrome, die from bacterial infections in early childhood, unless
properly treated [45]. These findings emphasize the importance of
neutrophils in the early clearance of bacteria. Interestingly, there
are indications that neutrophil function and ROS production is of
Figure 4. Monocyte proportion and function. (A) Percentage of
monocytes (Emr4
+ cells) in blood, as determined by FACS, in uninfected
LFD- (n=5) and HFD-fed (n=5) mice (Student’s t-test), and 5–7 days
after bacterial inoculation in LFD- (n=7) and HFD-fed (n=7) mice
(Welch’s t-test). (B) Emr1 mRNA expression in gonadal adipose tissue in
uninfected LFD- (n=8) and HFD-fed (n=8) mice, and in LFD- (n=12)
and HFD-fed (n=9) mice 5–7 days after bacterial inoculation. Welch’s t-
test. (C) Percentage of phagocytosing monocytes in uninfected LFD-
(n=5) and HFD-fed mice (n=5). Welch’s t-test. (D) Ingested bacteria per
monocyte in uninfected LFD- (n=5) and HFD-fed (n=5) mice. Student’s
t-test. In the scatter graphs, points represent individual mice (fold
change as compared with uninfected LFD-fed mice); group geometrical
means are denoted by a line throughout. Statistical comparisons are
made between LFD- and HFD-fed mice in both infected and uninfected
animals.
doi:10.1371/journal.pone.0007605.g004
Figure 5. Granulocyte proportion and function. (A) Percentage of
granulocytic neutrophils as determined by differential counts, in
uninfected LFD- (n=26) and HFD-fed (n=29) mice (Student’s t-test,
data are collected from 2 different experiments), and 5–7 days after
bacterial inoculation in LFD- (n=7) and HFD-fed (n=7) mice (Welch’s t-
test). (B) Percentage of phagocytosing granulocytes in uninfected LFD-
(n=5) and HFD-fed mice (n=5) (Student’s t-test), and 5–7 days after
inoculation in LFD- (n=14) and HFD-fed (n=13) mice (Student’s t-test
on log data that were collected from 2 different experiments). (C)
Ingested bacteria per granulocyte in uninfected LFD- (n=5) and HFD-
fed mice (n=5) (Student’s t-test), and 5–7 days after bacterial
inoculation in LFD- (n=14) and HFD-fed (n=13) mice (Student’s t-test
on log data that were collected from 2 different experiments).
doi:10.1371/journal.pone.0007605.g005
Figure 6. ROS production in lavage cells. ROS production 5–7 days
after bacterial inoculation in LFD- (n=7) and HFD-fed (n=6) mice.
Peritoneal lavage cells were left unstimulated or stimulated with or
PMA. ANCOVA on log data with experimental day as covariate.
doi:10.1371/journal.pone.0007605.g006
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subsequent resolution of the inflammation [43,46,47]. The role of
neutrophil function for HFD-associated inflammation remains to
be further investigated.
In line with our study, Leeman and coworkers recently reported
that HFD-induced obesity aggravates a local infection, the
periodontitis caused by Porphyromonas gingivalis [48]. These results
are of interest as it is well established that periodontitis is associated
with obesity [49]. Taken together with our findings it appears that
the immune response in general is decreased by HFD both with
regard to low-grade chronic local infection and acute life-
threatening generalized infection.
A limitation with the use of HFD-fed mice is that it is difficult to
determine whether it is the diet itself, or secondary causes thereof,
such as obesity or blood fat disturbances that influence the
immune system. For example, Kopf et al found that several
immune related parameters change in Apoe
2/2 mice given high fat
high cholesterol diet, as a model of dyslipidemia [50]. In this study
we fed C57BL/6 mice a HFD with a 30-time lower cholesterol
content, that do not cause major dyslipidemia in this strain [51].
Thus blood fat disturbances are an unlikely mediator of immune
suppression in our HFD-fed mice. Differences in diet may also
affect immune functions indirectly via effects on bacterial load
instead of vice versa. Furthermore, there is always a possibility of
species differences between mice and humans. For instance, the
proportion of neutrophils was decreased by HFD in uninfected
mice in this study, while neutrophils in blood seem to be higher in
obese humans [52].
In the present study we found increased mortality not only in
obese HFD-fed mice, but also in genetically obese Ob/Ob mice
that had not been given HFD. Complete lack of leptin activity is
associated with immune deficiencies in both mice and humans,
e.g. suppression of T-cells [53,54]. Therefore, it is possible that the
reason for increased mortality differ between Ob/Ob and HFD-
fed mice. This is supported by the fact that IL-1Ra and IL-10
response after LPS exposure is decreased in Ob/Ob mice [55],
although we observed higher levels of IL-1Ra and IL-10 in HFD-
fed obese mice in the present study. It should be noted that
complete lack of leptin activity is a very rare cause of severe obesity
in humans, while HFD-fed mice is generally accepted as a good
model for the common clinical obesity due to the combined effect
of high caloric density diet and multigenic predisposition [20,21].
Like obesity, sepsis and especially that caused by S. aureus is
increasing worldwide [1,2] and it is therefore urgent to understand
basic mechanisms and find better treatments for this condition.
The present study shows for the first time that HFD-fed mice,
despite their well known low-grade inflammation, have increased
mortality and bacterial proliferation in connection to sepsis. These
effects occurred several days after bacterial challenge, i.e. at a time
when mortality often occurs in clinical sepsis, not seldom because
of hypoinflammation [3,4]. The HFD-fed mice had disturbed
innate immune functions, as indicated by increased levels of
immune suppressing and immune stimulating cytokines and
decreased granulocyte function. Based on successful animal
studies, sepsis treatment in clinical trials has often sought to
decrease an early overactive immune response, but these drugs
have been largely ineffective [3–5]. Experimental studies have
usually been performed on lean young animals, while patients with
sepsis on average are 55–60 years old and often have several
symptoms of the metabolic syndrome [1]. We suggest that
experimental sepsis studies should be conducted in models that
are metabolically more similar to the clinical situation.
Supporting Information
Table S1 Primer and assays used for real-time RT PCR. F:
forward primer, R: reverse primer, *Tataa Biocenter, Gothen-
burg, Sweden
Found at: doi:10.1371/journal.pone.0007605.s001 (0.03 MB
DOC)
Table S2 Body weight, lean mass, and fat mass in 14 weeks old
male C57BL/6 mice after 8 weeks of LFD or HFD.
Found at: doi:10.1371/journal.pone.0007605.s002 (0.03 MB
DOC)
Figure S1 Flow cytometry plot gated with fluorochrome minus
one (FMO). Cells were obtained for a 4 color flow cytometry
analysis and stained as described in material and methods. By
removing one flourochrome from each staining, a negative control
(FMO) was obtained. FMO for (A) peridinin-chlorophyll-protein
(PerCP; CD8), (B) allophycocyanin (APC; CD4), (C) FITC (Emr1)
and (D) pacific blue (CD19) are shown as dot plots. Gating were
performed on mononuclear cells and then analyzed for the
background levels in the empty channel of each fluorochrome.
Found at: doi:10.1371/journal.pone.0007605.s003 (1.71 MB TIF)
Figure S2 Bacterial load after intravenous S. aureus inoculation.
(A) Bacterial load in blood 1 day after bacterial inoculation in lean
control (n=8) and DIO (n=6) mice. Mann-Whitney. (B) Bacterial
load in kidneys 1 day after bacterial inoculation in lean control
(n=8) and DIO (n=6) mice. Welch’s test.
Found at: doi:10.1371/journal.pone.0007605.s004 (1.59 MB
DOC)
Figure S3 Cytokine mRNA expression in liver. (A–E)
mRNA expression was measured in uninfected LFD- (n=8) and
HFD-fed (n=8) mice, and in LFD (n=14) and HFD-fed (n=11)
mice 5–7 days after bacterial inoculation. mRNA from the
Figure 7. Spleen weight and leukocyte fractions. (A) Spleen
weight in uninfected LFD- (n=13) and HFD-fed (n=13) mice, and 5–7
days after inoculation in LFD- (n=16) and HFD-fed (n=16) mice.
Student’s t-test on log data. Data were collected from 2 different
experiments. (B) Spleenic leukocyte fractions in uninfected LFD- (n=7)
and HFD-fed (n=8) mice. Emr1 (Welch’s t-test), CD4 (Student’s t-test),
CD8 (Student’s t-test), and CD19 (Student’s t-test) were used as markers
for monocytes/macrophages, T-helper, T cytotoxic, and B cells
respectively.
doi:10.1371/journal.pone.0007605.g007
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(D) Il1b, and (E) Tnf. Welch’s test. In the scatter graphs, points
represent individual mice (fold change as compared with
uninfected LFD-fed mice); group geometrical means are denoted
by a line throughout. Statistical comparisons are made between
LFD- and HFD-fed mice in both infected and uninfected animals.
Found at: doi:10.1371/journal.pone.0007605.s005 (5.34 MB TIF)
Figure S4 Cytokine mRNA expression in spleen. (A–E)
mRNA expression was measured in uninfected LFD- (n=8) and
HFD-fed (n=8) mice, and in LFD- (n=12) and HFD-fed (n=9)
mice 5–7 days after bacterial inoculation. mRNA from the
following cytokine genes were measured: (A) Il1rn, (B) Il10, (C) Il6,
(D) Il1b, and (E) Tnf. Welch’s test. In the scatter graphs, points
represent individual mice (fold change as compared with
uninfected LFD-fed mice); group geometrical means are denoted
by a line throughout. Statistical comparisons are made between
LFD- and HFD-fed mice in both infected and uninfected animals.
Found at: doi:10.1371/journal.pone.0007605.s006 (5.50 MB TIF)
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